Back to SYRE

DRIEHAUS CAPITAL MANAGEMENT LLC → SYRE

DRIEHAUS CAPITAL MANAGEMENT LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$245.8M
Q3 2026
Peak value
$248.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$94.4M
Q1 2026$140.8M
Q2 2026$248.5M
Q3 2026$245.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$245.8M2.76M——
Q2 2026$248.5M2.80M——
Q1 2026$140.8M2.79M——
Q4 2025$94.4M2.88M——

Other funds holding SYRE

Other DRIEHAUS CAPITAL MANAGEMENT LLC positions

TSMWF

TSMC

$657.5M
TSMWF

TSMC

$470.2M
TSMWF

TSMC

$427.5M
TSMWF

TSMC

$412.3M
DFTX

Definium Therapeutics Inc

$322M
PRAX

Praxis Precision Medicines Inc

$321.1M
PRAX

Praxis Precision Medicines Inc

$305.8M
CRNX

Crinetics Pharmaceuticals Inc

$297.3M